Patent details

EP3773910 Title: HUMANIZED ANTI-PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) ANTIBODY DRUG CONJUGATES

Basic Information

Publication number:
EP3773910
PCT Application Number:
US2019025057
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197171739
PCT Publication Number:
WO2019191728
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUMANIZED ANTI-PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) ANTIBODY DRUG CONJUGATES
French Title of Invention:
CONJUGUÉS MÉDICAMENT-ANTICORPS ANTI-ANTIGÈNE MEMBRANAIRE PROSTATIQUE SPÉCIFIQUE (PSMA) HUMANISÉ
German Title of Invention:
HUMANISIERTE ANTI-PROSTATA-SPEZIFISCHES MEMBRANANTIGEN(PSMA)-ANTIKÖRPER-ARZNEIMITTELKONJUGATE
SPC Number:

Dates

Filing date:
29/03/2019
Grant date:
24/07/2024
EP Publication Date:
17/02/2021
PCT Publication Date:
03/10/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2024
EP B1 Publication Date:
24/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/03/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2024
 
 

Name:
Ambrx, Inc.
Address:
10975 North Torrey Pines Road, La Jolla, CA 92037, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
26/07/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WANG, Jianing
Address:
United States (US)

2

Name:
BRADY, William
Address:
United States (US)

3

Name:
TIAN, Feng
Address:
United States (US)

4

Name:
XIA, Jinming
Address:
United States (US)

5

Name:
BHOWMIK, Shivarupam
Address:
United States (US)

Priority

Priority Number:
201862650277 P
Priority Date:
29/03/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61P 35/00; C07K 16/30; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
202430
Publication date:
24/07/2024
Description:
Grant (B1)

2

Issue number:
202435
Publication date:
28/08/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/03/2026
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
26/07/2024 Power Of Attorney 1
30/07/2024 Outgoing Correspondence 1